INmune Bio’s (INMB) “Neutral” Rating Reiterated at BTIG Research
INmune Bio (NASDAQ:INMB – Get Free Report)‘s stock had its “neutral” rating reiterated by stock analysts at BTIG Research in a research report issued on Tuesday, Marketbeat.com reports. Separately, Scotiabank restated a “sector underperform” rating on shares of INmune Bio in a research note on Tuesday. One research analyst has rated the stock with a […]
More Stories
Dow Jones Drops 500 Points, Oil Surges 8 Percent at Opening Bell
By Andrew Moran U.S. stocks fell and crude oil prices surged at the March 2 opening bell as investors reacted...
DHS Interdicts 6 Suspected Smuggling Vessels, Captures 82 Migrants off California Coast
By Naveen Athrappully Six suspected human smuggling boats were taken into custody by authorities during the weekend, the Department of...
China Conducts Patrol in South China Sea, Accuses Philippines of Disturbing Regional Peace
By Alex Wu The Chinese regime’s navy conducted patrols in the South China Sea from Feb. 23 to Feb. 26,...
Gulf States Say They’ve Shot Down More Than 1,500 Iranian Missiles, Drones
By John Haughey Five Persian Gulf nations that host U.S. military installations claim they have collectively shot down more than...
FBI Confirms Terrorism Task Force Investigating Texas Bar Shooting That Left 2 Dead
By Jack Phillips The FBI on March 1 stated that its terrorism task force has joined an investigation into a...
After Khamenei’s Death, Continued US–Israeli Strikes Push Iran’s Regime to Brink
By Emel Akan and Jacob Burg WASHINGTON—President Donald Trump on March 1 praised the joint U.S.–Israel military operation that killed...